T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFOR
751
Everforth Inc
EFOR
$1.37B
| $73.7M | 0.01% |
816,843
-105,266
| -11% | -$10.8M |
|
752
AtriCure
ATRC
$2.21B
| $73.5M | 0.01% |
1,799,414
-84,857
| -5% | -$4.02M |
|
753
Essential Properties Realty Trust
EPRT
$6.7B
| $72.8M | 0.01% |
3,389,904
+136,111
| +4% | +$3.16M |
|
754
Steven Madden
SHOO
$3.47B
| $72.1M | 0.01% |
2,237,042
-26,372
| -1% | -$1,000K |
|
|
TPTX
755
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $71.8M | 0.01% |
953,914
-3,008,738
| -76% | -$134M |
|
756
Moody's
MCO
$84.7B
| $71.7M | 0.01% |
263,626
-23,180
| -8% | -$6.93M |
|
757
Preferred Bank
PFBC
$1.27B
| $71.5M | 0.01% |
1,051,798
-50,536
| -5% | -$3.46M |
|
758
iRhythm Holdings
IRTC
$4.12B
| $71.5M | 0.01% |
662,185
+75,486
| +13% | +$10M |
|
|
PRA
759
DELISTED
ProAssurance
PRA
| $71.3M | 0.01% |
3,019,414
+60,057
| +2% | +$1.41M |
|
760
Semtech
SMTC
$12.4B
| $71.3M | 0.01% |
1,297,181
-9,283
| -0.7% | -$560K |
|
|
LSI
761
DELISTED
Life Storage, Inc.
LSI
| $71.1M | 0.01% |
637,191
+612,328
| +2,463% | +$75.6M |
|
762
CDW
CDW
$17.6B
| $71M | 0.01% |
450,684
-33,392
| -7% | -$5.61M |
|
|
FRC
763
DELISTED
First Republic Bank
FRC
| $70.9M | 0.01% |
491,599
-23,652
| -5% | -$3.55M |
|
764
EXL Service
EXLS
$5.36B
| $70.8M | 0.01% |
2,401,505
-135,005
| -5% | -$3.82M |
|
765
Enphase Energy
ENPH
$5.35B
| $70.7M | 0.01% |
362,184
-25,189
| -7% | -$4.55M |
|
766
Clearwater Paper
CLW
$352M
| $70.7M | 0.01% |
2,101,880
-199,440
| -9% | -$6.24M |
|
|
MRTX
767
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $70.6M | 0.01% |
1,051,530
-592,686
| -36% | -$37.7M |
|
768
Walker & Dunlop
WD
$1.46B
| $70.6M | 0.01% |
732,322
+15,124
| +2% | +$1.67M |
|
769
Euronet Worldwide
EEFT
$2.77B
| $70.5M | 0.01% |
700,898
-1,431,793
| -67% | -$170M |
|
770
Agilon Health
AGL
$1.53B
| $70.4M | 0.01% |
128,925
-7,508
| -6% | -$3.8M |
|
|
HONE
771
DELISTED
HarborOne Bancorp
HONE
| $69.7M | 0.01% |
5,057,397
-454,482
| -8% | -$6.28M |
|
772
Carpenter Technology
CRS
$26.5B
| $69.7M | 0.01% |
2,497,899
-34,576
| -1% | -$1.23M |
|
773
Unilever
UL
$135B
| $69.6M | 0.01% |
1,350,398
+1,281,830
| +1,869% | +$65.3M |
|
774
Huron Consulting
HURN
$2.47B
| $69.4M | 0.01% |
1,067,487
-493,177
| -32% | -$27.8M |
|
775
IQVIA
IQV
$39.7B
| $69.3M | 0.01% |
319,476
-30,178
| -9% | -$6.55M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.